谷歌Chrome浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

258MO Niraparib plus abiraterone acetate plus prednisone (NIRA+AAP) as first-line treatment in patients with BRCA+ metastatic castration-resistant prostate cancer (mCRPC): Second interim analysis in the Asian subgroup of the MAGNITUDE study

M. Saad,K.N. Chi,S.K. Sandhu,G. Attard, D. Ye,L. Li, W. Jung,S-T. Pang, P.S.J. Francis,S. Li,S. Dibaj, J. Zhang, W. Kim,A. Lopez-Gitlitz, D. Wu, A. Singh,R. De Vries, L. Zhang, J.Y. Lee

Annals of Oncology（2023）

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要